The EPA's Microplastics Move: A Win or Just the Beginning of a Long Stall?

The EPA just announced it’s adding microplastics and pharmaceuticals to its Contaminant Candidate List for the first time. Sound like a big deal? It might be. Or it might be the environmental equivalent of a politician kissing a baby at a campaign stop.

According to reporting from the Associated Press, EPA Administrator Lee Zeldin made the announcement Thursday, framing it as a direct response to Americans worried about what’s floating in their drinking water. The move also serves another purpose: it hands a symbolic win to Robert F. Kennedy Jr.’s MAHA movement, which has been breathing down the EPA’s neck for months demanding tougher action on environmental contaminants.

Here’s the thing though. Getting on this list is supposed to be the first step toward regulation. But the EPA’s track record suggests it might be more of a dead end.

The Watchlist That Rarely Leads Anywhere

The Contaminant Candidate List exists to help the EPA prioritize research and funding. It’s basically the agency saying “we see you, we’re paying attention.” Except it rarely translates into actual rules limiting how much of these substances can be in your water.

Erik Olson, a senior attorney at the Natural Resources Defense Council, put it bluntly in AP reporting: “It’s the beginning of a very long process that routinely ends in nothing.”

That assessment isn’t pessimism. It’s pattern recognition. In five previous cycles of this process, the EPA has decided that most contaminants on the list don’t warrant regulatory action. Last March alone, the agency said it wouldn’t develop regulations for nine pollutants it had examined.

The law requires the EPA to determine whether to regulate at least five contaminants from each version of the list. But “determine whether to regulate” and “actually regulate” are two very different things.

What Scientists Say We Should Worry About

The science behind microplastics is still evolving, and that’s part of the problem. Studies have found microplastics in people’s hearts, brains, and testicles. Doctors and scientists are assessing what this actually means for human health, but the consensus is clear: there’s cause for concern.

Pharmaceutical residue in drinking water is another story. Humans excrete drugs, and conventional wastewater treatment plants don’t remove them. That means your neighbor’s antidepressants or antibiotics could be in your tap water. We’re still learning what the long-term effects might be.

The science is legitimate. The response, though, feels measured in political increments rather than public health urgency.

The Industry Plays It Safe

The American Chemistry Council, representing plastic manufacturers, said it supports monitoring microplastics in drinking water. But with a caveat: the monitoring needs to be standardized and consistent.

Translation: let’s study this carefully so we can manage expectations and avoid costly regulations later.

Meanwhile, the Trump administration has moved in the opposite direction on other fronts. In May, the EPA announced plans to rescind limits on certain “forever chemicals” that the Biden administration had just finalized. Environmental advocates are fighting to keep those protections in place. So while the administration gestures toward addressing microplastics, it’s simultaneously rolling back other drinking water safeguards.

Kennedy’s $144 Million Bet

Kennedy, whose 2024 presidential campaign leaned heavily on plastic pollution concerns, announced a $144 million initiative called STOMP (Systematic Targeting of Microplastics). The goal is to build tools to detect microplastics, map how they move through the body, and eventually remove them.

“We can’t treat what we cannot measure, we cannot regulate what we don’t understand,” Kennedy said at the EPA. It’s a fair point. But it’s also a statement that hints at how far behind we are on this issue.

The funding is substantial. But it also reveals something uncomfortable: we’re investing heavily in understanding and removing microplastics from human bodies because we haven’t stopped them from getting there in the first place.

The Global Problem Nobody Wants to Solve

Dr. Philip Landrigan, director of the Global Observatory on Planetary Health at Boston College, flagged a critical issue: none of this matters much if the U.S. doesn’t rein in plastic production itself.

The United States is participating in international talks on a global plastic pollution treaty. But the country strongly opposes limits on plastic production. So we’re willing to monitor and study and eventually remove microplastics from drinking water, but not willing to make less plastic.

It’s the environmental equivalent of mopping the floor while leaving the faucet running.

What Comes Next

The EPA is opening a 60-day public comment period on this new draft list. It expects to finalize it by mid-November. Organizations like Food & Water Watch say the listing is important but falls short of what’s needed. The Natural Resources Defense Council views it as a step forward, though one with no guaranteed destination.

Some environmental groups see this as real progress. Others see a process designed to create the appearance of action while the regulatory machinery grinds slowly enough that most contaminants never actually get regulated.

The real test won’t come from whether microplastics make the list. It’ll come from whether they ever make it off the list as actual regulated substances with enforceable limits. Given the EPA’s history, don’t hold your breath.

Written by

Adam Makins

I’m a published content creator, brand copywriter, photographer, and social media content creator and manager. I help brands connect with their customers by developing engaging content that entertains, educates, and offers value to their audience.